SSHA CONFERENCE 2013 Summary In July 2012, the US Food and Drugs Administration approved the use of a daily regimen of oral Truvada (tenofovir co-formulated with emtricitabine) as pre-exposure prophylaxis (PrEP) to reduce the sexual acquisition of HIV infection. Based on the existing evidence, the British Association of Sexual Health and HIV (BASHH) and British HIV … [Read more...]